HR
VIVO

Howe & Rusling’s Meridian Bioscience Inc VIVO Stock Holding History

Howe & Rusling’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-53
Closed -$1K – 1101
2021
Q4 		$1K Hold
53
– – ﹤0.01% 975
2021
Q3 		$1K Hold
53
– – ﹤0.01% 963
2021
Q2 		$1K Buy
+53
New +$1.12K ﹤0.01% 929
2021
Q1 		– Sell
-50
Closed -$1K – 1037
2020
Q4 		$1K Buy
+50
New +$934 ﹤0.01% 917
2014
Q2 		– Sell
-1,096
Closed -$24K – 945
2014
Q1 		$24K Buy
+1,096
New +$25.1K 0.01% 432
2013
Q4 		– Sell
-1,096
Closed -$26K – 896
2013
Q3 		$26K Hold
1,096
– – 0.01% 433
2013
Q2 		$24K Buy
+1,096
New +$23.6K 0.01% 462

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howe & Rusling's VIVO Position: Q1 2022 in Review

Howe & Rusling sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 53 shares — an estimated $1K sold.

Howe & Rusling first reported a position in VIVO in Q2 2013 and held it in 7 quarters. The position peaked at $26K in Q3 2013. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Howe & Rusling reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
  • Howe & Rusling sold 53 Meridian Bioscience Inc shares in Q1 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 7 quarters.
  • Howe & Rusling's Meridian Bioscience Inc position peaked at $26K in Q3 2013.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Howe & Rusling's 13F filing for Q1 2022, filed 10 May 2022.